ProfileGDS5678 / 1431244_s_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 11% 11% 11% 11% 10% 12% 12% 11% 11% 11% 11% 11% 11% 11% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.2962311
GSM967853U87-EV human glioblastoma xenograft - Control 22.2771511
GSM967854U87-EV human glioblastoma xenograft - Control 32.2801111
GSM967855U87-EV human glioblastoma xenograft - Control 42.2354211
GSM967856U87-EV human glioblastoma xenograft - Control 52.2123610
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.3565512
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.3147712
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.2618511
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.2572811
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.2741511
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.2638311
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.2587211
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.2678911
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.2720911